Loading…
Balaji Phosphates (BALAJIPHOS)₹129.65+2.73%Fertilizers
In the Mar 2026 quarter (consolidated), Balaji Phosphates reported sales of ₹86.09 Cr, up 34.3% from Mar 2025, and net profit of ₹2.01 Cr, down 49.9% year on year. For the year to Mar 2026, sales were ₹170 Cr and net profit ₹10.01 Cr.
Company filings, consolidated accounts; latest reported quarter Mar 2026
| Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Sales | 55.06 | 62.08 | 64.08 | 85.15 | 86.09 |
| Expenses | 51.96 | 55.90 | 56.91 | 71.89 | 78.88 |
| Operating Profit | 3.01 | 6.01 | 7.02 | 13.03 | 6.02 |
| OPM % | 6.0% | 10.0% | 11.0% | 15.0% | 7.0% |
| Other Income | 0.00 | 1.99 | 0.00 | 1.01 | 0.00 |
| Interest | 2.01 | 2.01 | 2.01 | 2.01 | 2.01 |
| Depreciation | 0.00 | 0.00 | 1.01 | 0.99 | 1.01 |
| Profit before tax | 0.99 | 5.97 | 4.98 | 10.96 | 3.98 |
| Tax % | 30.0% | 24.0% | 27.0% | 26.0% | 47.0% |
| Net Profit | 1.01 | 4.01 | 4.01 | 8.01 | 2.01 |
| EPS (Rs) | 0.48 | 2.42 | 1.50 | 3.38 | 0.91 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Sales | 59.04 | 103 | 127 | 145 | 152 | 127 | 170 |
| Expenses | 51.93 | 97.89 | 120 | 133 | 139 | 113 | 151 |
| Operating Profit | 7.01 | 5.01 | 8.02 | 12.03 | 12.03 | 13.04 | 19.05 |
| OPM % | 12.0% | 4.9% | 6.0% | 8.0% | 8.0% | 11.0% | 11.0% |
| Other Income | 0.99 | 0.00 | 0.99 | 0.00 | 0.00 | 2.01 | 0.99 |
| Interest | 2.01 | 2.01 | 3.01 | 3.01 | 3.01 | 4.01 | 4.01 |
| Depreciation | 1.01 | 0.99 | 0.99 | 0.99 | 1.01 | 1.01 | 1.01 |
| Profit before tax | 3.98 | 1.99 | 4.98 | 7.97 | 7.98 | 10.96 | 14.94 |
| Tax % | 43.0% | 45.0% | 30.0% | 26.0% | 28.0% | 26.0% | 32.0% |
| Exceptional items | 0.00 | −0.08 | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 |
| Net Profit | 3.01 | 1.01 | 3.01 | 6.01 | 6.01 | 8.01 | 10.01 |
| EPS (Rs) | — | 2.26 | 5.42 | 6.82 | 3.38 | 3.32 | 4.29 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 8.01 | 5.99 | 6.01 | 9.01 | 17.98 | 23.98 | 23.97 |
| Reserves | 11.02 | 15.04 | 18.05 | 20.05 | 17.00 | 56.09 | 67.07 |
| Borrowings | 14.06 | 20.09 | 20.08 | 26.11 | 33.06 | 31.10 | 42.12 |
| Other Liabilities | 25.90 | 31.88 | 39.90 | 41.79 | 19.91 | 12.94 | 29.86 |
| Total Liabilities | 58.99 | 72.00 | 83.04 | 96.96 | 87.95 | 124 | 163 |
| Fixed Assets | 7.98 | 12.97 | 12.96 | 11.97 | 11.96 | 11.97 | 11.96 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.01 | 12.03 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 52.01 | 59.03 | 70.08 | 84.99 | 76.99 | 111 | 139 |
| Inventories | 18.95 | 21.93 | 23.92 | 41.86 | 30.88 | 39.88 | 57.77 |
| Trade receivables | 24.06 | 26.08 | 29.08 | 30.11 | 31.10 | 45.13 | 68.22 |
| Cash & equivalents | 0.00 | 0.99 | 1.99 | 2.99 | 1.99 | 1.99 | 1.99 |
| Total Assets | 58.99 | 72.00 | 83.04 | 96.96 | 87.95 | 124 | 163 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from operating activity | 5.97 | 6.97 | 2.99 | −3.99 | −2.99 | −35.87 | 4.98 |
| Cash from investing activity | 0.00 | −7.03 | −1.01 | 0.00 | −1.01 | 5.02 | −13.06 |
| Cash from financing activity | −6.02 | 1.01 | −2.01 | 4.01 | 4.01 | 31.10 | 8.03 |
| Net cash flow | 0.00 | 1.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capex | 0.00 | 0.00 | 0.00 | 0.10 | 0.87 | 3.78 | 12.33 |
| Free cash flow | 5.98 | 13.96 | 2.99 | −3.99 | −3.99 | −38.91 | −7.98 |
| CFO / OP % | 108.0% | 159.0% | 55.1% | −20.9% | −8.9% | −237.9% | 30.1% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor days | 149 | 93 | 82 | 76 | 75 | 129 | 145 |
| Inventory days | 196 | 116 | 94 | 152 | 106 | 173 | 186 |
| Days payable | 169 | 125 | 60 | 70 | 33 | 31 | 62 |
| Cash conversion cycle | 175 | 83 | 116 | 157 | 148 | 271 | 270 |
| Working capital days | 103 | 49 | 51 | 59 | 68 | 175 | 153 |
| ROCE % | — | 11.9% | 17.0% | 22.0% | 18.9% | 15.9% | 15.0% |
For the Mar 2026 quarter, Balaji Phosphates reported sales of ₹86.09 Cr, up 34.3% year on year and net profit of ₹2.01 Cr, down 49.9% year on year. The operating margin was 7.0%.
Balaji Phosphates' sales for the year to Mar 2026 were ₹170 Cr.
Net profit for the year to Mar 2026 was ₹10.01 Cr. Earnings per share over the same trailing period were ₹4.29.
Balaji Phosphates reported borrowings of ₹42.12 Cr at Mar 2026, against cash and equivalents of ₹1.99 Cr.
Cash from operations was ₹4.98 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹7.98 Cr.